SEC Form 4 · accession 0001209191-15-023675

PharMerica CORP · PMC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, GC and Secretary

Period of report

Mar 4, 2015

Accepted (ET)

Mar 6, 2015 · 5:52 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001388195

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.01 par value	Mar 4, 2015	M	25,000	$14.89	A	97,967	D
Common Stock, $0.01 par value	Mar 4, 2015	M	33,565	$18.48	A	131,532	D
Common Stock, $0.01 par value	Mar 4, 2015	F	46,229	$27.39	D	85,303	D
Common Stock, $0.01 par value^F1	Mar 5, 2015	S	17,253	$27.0247	D	68,050	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$14.89	Mar 4, 2015	M	25,000	D	—	Mar 3, 2016	Common Stock, $.01 par value	25,000	0	D
Stock Option (Right to Buy)^F3	$18.48	Mar 4, 2015	M	33,565	D	—	Mar 3, 2017	Common Stock, $.01 par value	33,565	0	D

F1This transaction was executed in multiple trades at prices ranging from $27.00 to $27.09, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2The options vested in the following amounts on the following dates: 10,197 options on 03/03/2010, 10,197 options on 03/03/2011, 10,197 options on 03/03/2012 and 10,200 options on 03/03/2013.
F3The options vested in the following amounts on the following dates: 8,392 options on 03/16/2011, 8,391 options on 03/16/2012, 8,391 options on 03/16/2013 and 8,391 options on 03/16/2014.